Werewolf Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $139.3M | $143.7M |
| Jun 2022 | — | $129.8M | $145.7M |
| Sep 2022 | — | $130.9M | $140.5M |
| Dec 2022 | — | $122.3M | $129.3M |
| Mar 2023 | — | $121.1M | $147.9M |
| Jun 2023 | — | $118.6M | $137.5M |
| Sep 2023 | — | $112.4M | $130.1M |
| Dec 2023 | $40.0M | $111.4M | $134.3M |
| Mar 2024 | $40.0M | $117.6M | $139.2M |
| Jun 2024 | $32.1M | $104.0M | $135.3M |
| Sep 2024 | $32.1M | $89.4M | $122.8M |
| Dec 2024 | $32.1M | $73.4M | $111.0M |
| Mar 2025 | $32.1M | $57.3M | $92.0M |
| Jun 2025 | $32.1M | $41.5M | $77.6M |
| Sep 2025 | $32.1M | $29.6M | $65.7M |
| Dec 2025 | $32.1M | $24.8M | $57.1M |
| Mar 2026 | $32.1M | $12.2M | $46.5M |
| Jun 2026 | — | $16.3M | $22.0M |